Partners in Control, Phase II: Using Remote Monitoring Technology With Community Health Workers to Support Hypertension Management for Latinx Patients
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- NYU Langone Health
- Enrollment
- 300
- Locations
- 2
- Primary Endpoint
- Change in systolic blood pressure
Study Overview
Brief Summary
This study seeks to evaluate the impact of a remote patient monitoring (RPM)-specific tech-enabled community health worker workforce on the use of RPM for the management of hypertension among Latinx patients. This study is a step-wedge randomized controlled trial that aims to assess the effectiveness and implementation of RPM-enabled community health workers (CHWs) compared to standard of care RPM hypertension management on blood pressure reduction and evaluate the implementation of the RPM-enabled CHWs for hypertension (HTN) management. The study aims to examine adoption, acceptability, fidelity, cost, sustainability, and equity as outcomes of implementation effectiveness.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Supportive Care
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Self-identify as Latinx
- •Be fluent in English or Spanish
- •Be age 18 years or older
- •Receiving care at one of the 10 safety-net primary care clinics
- •Have uncontrolled HTN documented in the electronic health record (EHR) on at least two visits in the past year (defined as an average BP ≥ 140/90 mmHg)
- •Have been prescribed at least one anti-hypertensive medication and be non-adherent to their medications, defined as adherence <80% in the preceding 12 months, as determined by prescription orders obtained from the clinic EHR.
Exclusion Criteria
- •Being deemed unable to comply with the study protocol (either self-selected or by indicating during screening that s/he could not complete all requested tasks)
- •Participation in other hypertension-related clinical trials
- •Have significant psychiatric comorbidity or reports of substance abuse (as documented in the EHR)
- •Plan to discontinue care at the clinic within the next 15 months
Outcomes
Primary Outcomes
Change in systolic blood pressure
Time Frame: Baseline, Month 18
Change in diastolic blood pressure
Time Frame: Baseline, Month 18
Secondary Outcomes
- Rate of hypertension control(Month 18)